| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/22/2005 | WO2005087770A2 5,6-dihydrocarbyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 09/22/2005 | WO2005087766A1 Hiv integrase inhibitors |
| 09/22/2005 | WO2005087762A1 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug each comprising the same |
| 09/22/2005 | WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders |
| 09/22/2005 | WO2005087741A1 PHOTOCHARGE SEPARATION USING SUPRAMOLECULAR COMPLEX OF π-ELECTRON TYPE EXTENDED VIOLOGEN DERIVATIVE AND PORPHYRIN |
| 09/22/2005 | WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 09/22/2005 | WO2005056547A3 Quinoxalines useful as inhibitors of protein kinases |
| 09/22/2005 | WO2004112480A3 Triazolopyrimidines |
| 09/22/2005 | WO2004096807A8 Hiv integrase inhibitors |
| 09/22/2005 | US20050209487 Asymmetric hydrogenation of dialkyl, alkylalkenyl or dialkenyl imines in the presence of H2 and a catalytic system of a base and a ruthenium complex containing a diamine and a diphosphine ligand or monodentate phosphine ligands |
| 09/22/2005 | US20050209470 Diastereoselective epoxidation of allylically substituted alkenes using metalloporphyrin catalysts |
| 09/22/2005 | US20050209456 Vascular endothelial growth factor; tyrosine kinase inhibitor; angiogenesis inhibitor; anticancer agents |
| 09/22/2005 | US20050209454 Synthetic process |
| 09/22/2005 | US20050209298 treating rheumatoid arthritis by photodynamic therapy (PDT), by administering an iminochlorin aspartic acid porphyrin derivative called ATX-S10 sodium salt; determining the location of a sentinel lymph node and the presence of cancer metastasis; compounds from US patent 6063777 |
| 09/22/2005 | US20050209273 Neuroprotectants, analgesics or anticonvulsants |
| 09/22/2005 | US20050209268 Administering optionally hydrogenated 2-alkyl-1-(alkylsulfonylalkyl)imidazo[4,5-c]quinoline-4-amines to induce biosynthesis of cytokines such as IFN-alpha and/or TNF-alpha; treating viral diseases and neoplastic diseases |
| 09/22/2005 | US20050209256 Novel beta-turn mimetics as calcitonin gene related peptide receptor antagonists |
| 09/22/2005 | US20050209255 Compositions useful as inhibitors of protein kinases |
| 09/22/2005 | US20050209253 Corticotropin releasing factor (CRF) receptor antagonists; nervous system disorders, ischemia, gastrointestinal disorders, hypertension, eating disorders, sleep disorders; e.g. 2-(1-[7-(2,6-dibromo-4-trifluoromethyl-phenyl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-piperidin-2-yl)-ethanol |
| 09/22/2005 | US20050209251 Substituted pyrazolo-pyrimidine-4-ones |
| 09/22/2005 | US20050209247 Lactate salt of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one; improved water solubility and physicochemical properties (e.g., stability, hygroscopicity, crystallinity, and compactibility); vascular endothelial growth factor receptor tyrosine kinase inhibitors |
| 09/22/2005 | US20050209235 Tyrosine kinase inhibitors; antiproliferative agent; 2-(4-{4-[1-(3-Fluoro-benzyl)-1H-indazol-5-ylamino]-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl}-[1,4]diazepan-1-yl)-ethanol combined with anticarncer agent selected from tamoxifen, toremifen, raloxifene, droloxifene, iodoxyfene, megestrol acetate and other |
| 09/22/2005 | US20050209234 4-Oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 09/22/2005 | US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline |
| 09/22/2005 | US20050209212 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; improvement over imipenem |
| 09/22/2005 | US20050208668 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same |
| 09/22/2005 | US20050208667 Contacting aromatic monomer and template with assembled hematin to produce conductive polyaromatic polymers for use in electronic devices |
| 09/22/2005 | US20050208666 Hematin deposited on electrically charged substrate in one or more layers alternating with one or more layers of polyelectrolyte, preferably a cationic polymer; potential use as polymerization catalyst for polyanilines, polythiophenes, polypyrroles, and polyphenols; carbon nanotubes |
| 09/22/2005 | US20050208582 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 09/22/2005 | US20050205895 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device |
| 09/22/2005 | CA2559444A1 Imidazopyridazine diones, the production thereof, and the use of the same as a medicament |
| 09/22/2005 | CA2557926A1 Hiv integrase inhibitors |
| 09/22/2005 | CA2557815A1 5,6-dihydrocarbyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 09/22/2005 | CA2557779A1 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 09/21/2005 | EP1577312A1 Triazolopyrimidine intermediate compounds for fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 09/21/2005 | EP1577311A1 Salts of a pyridazino aquinoline derivative and use for the treatment of pain |
| 09/21/2005 | EP1577301A1 Diamine derivatives |
| 09/21/2005 | EP1576015A2 Preparation of metallotexaphyrins |
| 09/21/2005 | EP1575959A2 Compositions useful as inhibitors of protein kinases |
| 09/21/2005 | EP1575958A1 Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines |
| 09/21/2005 | EP1575957A1 2-mercapto-substituted triazolopyrimidines, methods for the production thereof, the use of the same for controlling pathogenic fungi, and agents containing said compounds |
| 09/21/2005 | EP1575955A1 Pyrrolobenzodiazepines |
| 09/21/2005 | EP1575954A2 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 09/21/2005 | EP1575952A1 Synthesis of heteroaryl acetamides |
| 09/21/2005 | EP1575934A1 Carbazole derivatives and their use as npy-5 antagonists |
| 09/21/2005 | EP1575925A1 Novel carboxamides, the production and use thereof as medicaments |
| 09/21/2005 | EP1575923A2 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST &bgr;-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE |
| 09/21/2005 | EP1575493A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| 09/21/2005 | EP1220857B1 Gonadotropin releasing hormone receptor antagonists and their related methods of use |
| 09/21/2005 | EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors |
| 09/21/2005 | EP1042325B1 Nitrogen-containing heterocyclic compounds, their production and use |
| 09/21/2005 | CN1671800A Fibre-reactive azo dyes, their preparation and their use |
| 09/21/2005 | CN1671711A Calcitonin gene related peptide receptor antagonists |
| 09/21/2005 | CN1671710A Pyrazolo[1, 5a]pyrimidine compounds as antiviral agents |
| 09/21/2005 | CN1671709A Pyrazolopyrimidines and the use thereof for controlling harmful organisms |
| 09/21/2005 | CN1671708A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 09/21/2005 | CN1671707A Novel process for producting imidazo[1, 2-b]pyridazine derivative |
| 09/21/2005 | CN1219781C 2-alkoxycarbonylmethylthiotriazolopyrimidine compound and its preparation method |
| 09/21/2005 | CN1219780C Heterocyclic compounds binding chemotactic factor receptor |
| 09/21/2005 | CN1219511C Method for curing sepsis |
| 09/20/2005 | US6946562 Solid phase synthesis of ballasted dye-forming azole couplers including reacting amino functionalized azole compound with polystyrene bound peptoid oligomer, then cleaving from the resin surface with fluorinated acid solvent |
| 09/20/2005 | US6946554 Process for the preparation of 9-deazaguanine derivatives |
| 09/20/2005 | US6946478 Compounds |
| 09/20/2005 | US6946473 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis |
| 09/20/2005 | US6946464 Methods of treating and preventing a convulsive state |
| 09/20/2005 | US6946461 Cognition activators |
| 09/20/2005 | US6946459 Crystalline forms of 1s-[1alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl) carbonyl]amino]octahydro-6h-piridazino[1,2-a][1,2]diazepin-1-carboxamide |
| 09/20/2005 | US6946455 Interstrand crosslinking agents for DNA and compounds therefor |
| 09/20/2005 | US6946116 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 09/20/2005 | US6946005 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers |
| 09/20/2005 | CA2236588C Water soluble cross-linking agents |
| 09/20/2005 | CA2188796C Heterocyclylbenzonitriles |
| 09/20/2005 | CA2084582C Process for the production of mono-n-substituted tetraaza macrocycles |
| 09/15/2005 | WO2005085259A2 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 09/15/2005 | WO2005085254A1 Process for inhibiting cell proliferation |
| 09/15/2005 | WO2005085253A1 Pyrrolopyrimidine derivatives |
| 09/15/2005 | WO2005085252A1 Imidazo ‘1,2-a’ pyrazine compounds which interact with protein kinases |
| 09/15/2005 | WO2005085251A1 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines |
| 09/15/2005 | WO2005085250A1 C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases |
| 09/15/2005 | WO2005085249A1 Fused derivatives of pyrazole |
| 09/15/2005 | WO2005085248A1 Heteroaryl-fused pyrazolo derivatives |
| 09/15/2005 | WO2005085228A1 Cycloalkanopyridine derivative |
| 09/15/2005 | WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient |
| 09/15/2005 | WO2005085200A1 Pyridone derivative |
| 09/15/2005 | WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers |
| 09/15/2005 | WO2005084667A1 Bicyclic and bridged nitrogen heterocycles |
| 09/15/2005 | WO2005084439A1 2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
| 09/15/2005 | WO2005084295A2 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 |
| 09/15/2005 | WO2005065416A3 Process for the preparation of pyridopyrimidones |
| 09/15/2005 | WO2005056066A3 Ph dependent medicinal compositions |
| 09/15/2005 | WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof |
| 09/15/2005 | WO2005039484A3 Indolocarbazole anticancer agents and methods of using same |
| 09/15/2005 | WO2004101516A3 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 09/15/2005 | US20050203299 Slurrying aripiprazole in a solvent (acetone), heating and isolating anhydrous aripiprazole Form II from the slurry |
| 09/15/2005 | US20050203298 improves yields by avoiding the use of chlorosulphonic acid so no imidazotriazinonesulphonyl chlorides are formed as intermediates ; 4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazol[5,1-fl-[1,2,4]triazin-2-yl)benzenesulphonic acid |
| 09/15/2005 | US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 09/15/2005 | US20050203276 Aromatic monomer is combined with hematin catalyst derivatized with non-proteinaceous amphipathic group (polyoxyethylene glycol), peroxide initiator, and template |
| 09/15/2005 | US20050203275 Methods for polymerization of electronic and photonic polymers |
| 09/15/2005 | US20050203147 Biaryl heterocyclic compounds and methods of making and using the same |
| 09/15/2005 | US20050203123 Substituted piperidine compounds and methods of their use |